| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012669684 |
| P356 | DOI | 10.1186/BCR2590 |
| P932 | PMC publication ID | 2917031 |
| P698 | PubMed publication ID | 20565864 |
| P5875 | ResearchGate publication ID | 44690374 |
| P50 | author | Johan Vallon-Christersson | Q30002264 |
| Markus Ringnér | Q37374913 | ||
| Håkan Olsson | Q59659715 | ||
| Johan Staaf | Q88985771 | ||
| Åke Borg | Q89371995 | ||
| Göran Jönsson | Q90142117 | ||
| Karolina Holm | Q114337467 | ||
| Cecilia Hegardt | Q114337468 | ||
| P2860 | cites work | The CD44+/CD24- phenotype is enriched in basal-like breast tumors | Q21092906 |
| Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals | Q22122053 | ||
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics | Q24595882 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 | ||
| Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin | Q27851546 | ||
| Gene Expression Omnibus: NCBI gene expression and hybridization array data repository | Q27860523 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| A gene hypermethylation profile of human cancer | Q28213253 | ||
| Control of developmental regulators by Polycomb in human embryonic stem cells | Q28235841 | ||
| TM4: a free, open-source system for microarray data management and analysis | Q29547339 | ||
| Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions | Q29614512 | ||
| An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors | Q29615393 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| ''R"--project for statistical computing | Q29618640 | ||
| Genomic and transcriptional aberrations linked to breast cancer pathophysiologies | Q29619120 | ||
| Polycomb silencers control cell fate, development and cancer | Q29619697 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| The molecular portraits of breast tumors are conserved across microarray platforms | Q33241398 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization | Q33276605 | ||
| New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling | Q33392210 | ||
| Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer | Q33865946 | ||
| High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer | Q34048024 | ||
| Stem cells and cancer; the polycomb connection | Q34341685 | ||
| High-throughput DNA methylation profiling using universal bead arrays | Q34483135 | ||
| Evidence for an instructive mechanism of de novo methylation in cancer cells. | Q34489258 | ||
| Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells | Q34619655 | ||
| Suz12 binds to silenced regions of the genome in a cell-type-specific manner | Q34703113 | ||
| Relevance of DNA methylation in the management of cancer | Q35146155 | ||
| Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. | Q36787353 | ||
| EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer | Q37131382 | ||
| Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. | Q37321816 | ||
| Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment | Q37324446 | ||
| Array-based DNA methylation profiling in follicular lymphoma | Q37388672 | ||
| Polycomb group proteins: navigators of lineage pathways led astray in cancer | Q37620148 | ||
| Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification | Q40951949 | ||
| Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers | Q42457867 | ||
| Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome | Q42468745 | ||
| Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation | Q44364520 | ||
| Genetic alterations and oncogenic pathways associated with breast cancer subtypes | Q46047984 | ||
| Polycomb group protein ezh2 controls actin polymerization and cell signaling. | Q53676862 | ||
| Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes | Q57660183 | ||
| P433 | issue | 3 | |
| P921 | main subject | DNA methylation | Q874745 |
| breast cancer | Q128581 | ||
| P304 | page(s) | R36 | |
| P577 | publication date | 2010-06-18 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns | |
| P478 | volume | 12 |
| Q35914847 | A DNA hypermethylation module for the stem/progenitor cell signature of cancer. |
| Q41135908 | A DNA methylation-based definition of biologically distinct breast cancer subtypes |
| Q35069999 | A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology |
| Q42376133 | A new semi-supervised learning model combined with Cox and SP-AFT models in cancer survival analysis |
| Q91690995 | A novel Log penalty in a path seeking scheme for biomarker selection |
| Q33599244 | A novel method for identification and quantification of consistently differentially methylated regions |
| Q38547141 | Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes |
| Q37354053 | Aberrant promoter CpG methylation and its translational applications in breast cancer. |
| Q37655854 | Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. |
| Q33817330 | Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer |
| Q36628822 | An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells. |
| Q46306467 | Analysis of breast cancer subtypes by AP-ISA biclustering |
| Q35558105 | Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes |
| Q33689442 | Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination |
| Q42465688 | Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study |
| Q46204355 | BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC. |
| Q41274606 | BRCA2 carriers with male breast cancer show elevated tumour methylation |
| Q36741554 | CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer |
| Q37458486 | Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling |
| Q38783085 | Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature |
| Q43909947 | Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours. |
| Q34547465 | Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study |
| Q38990723 | Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes |
| Q64243651 | Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection |
| Q38810340 | Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the Epigenome. |
| Q35584026 | Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis. |
| Q36154959 | DNA Methylation Patterns in Rat Mammary Carcinomas Induced by Pre- and Post-Pubertal Irradiation. |
| Q64940251 | DNA Methylation Profiles and Their Diagnostic Utility in BC. |
| Q36187834 | DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status |
| Q43700782 | DNA methylation at enhancers identifies distinct breast cancer lineages |
| Q34989097 | DNA methylation epigenotypes in breast cancer molecular subtypes |
| Q35987862 | DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study |
| Q41132483 | DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables |
| Q35000317 | DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival |
| Q36038847 | DNA methylation profiling reveals a predominant immune component in breast cancers. |
| Q36833424 | DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer |
| Q37702047 | DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival |
| Q38261602 | DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment |
| Q37655029 | DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk. |
| Q37109790 | Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer |
| Q37321765 | Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns |
| Q42496731 | Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes |
| Q36038724 | Divide and conquer: the genetic basis of molecular subclassification of breast cancer |
| Q92683767 | Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions |
| Q34000392 | Effect of estrogen receptor α binding on functional DNA methylation in breast cancer |
| Q42367979 | Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer |
| Q52332848 | Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer. |
| Q24629061 | Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells |
| Q38296760 | Epigenetic mechanisms of breast cancer: an update of the current knowledge |
| Q35190483 | Epigenetics in breast and prostate cancer |
| Q26991779 | Epigenetics in breast cancer: what's new? |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q33739319 | Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis |
| Q91989229 | Estimating the magnitude of clinical benefit from (neo)adjuvant chemotherapy in patients with ER-positive/HER2-negative breast cancer |
| Q37629774 | Evidence for a Functional Link between Chromosomal Breakpoints and Aberrant DNA Methylation in Cancer |
| Q39625095 | Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups |
| Q38789560 | FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS. |
| Q42501865 | GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer |
| Q55030444 | Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers. |
| Q37709387 | Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer. |
| Q41136382 | Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes |
| Q34196315 | Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis |
| Q35841605 | Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence |
| Q39430136 | Genome-wide methylation analysis of DNMT3B gene isoforms revealed specific methylation profiles in breast cell lines |
| Q37649665 | Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry |
| Q61799198 | Genome-wide promoter methylation of hairy cell leukemia |
| Q34964303 | Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer |
| Q34647477 | Genomic insights into cancer-associated aberrant CpG island hypermethylation |
| Q37933098 | Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers |
| Q35002412 | Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers |
| Q39319266 | Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes |
| Q39042751 | Glycan-related gene expression signatures in breast cancer subtypes; relation to survival |
| Q38175087 | Harnessing the potential of epigenetic therapy to target solid tumors. |
| Q34425230 | Hereditary breast cancer: clinical, pathological and molecular characteristics |
| Q55229889 | Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. |
| Q33556583 | Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients |
| Q52720003 | Identification of methylation sites and signature genes with prognostic value for luminal breast cancer. |
| Q37872301 | Implications of genomic instability in the diagnosis and treatment of breast cancer |
| Q35370090 | Insight into the heterogeneity of breast cancer through next-generation sequencing |
| Q30910707 | Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients |
| Q37224735 | Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer |
| Q28305345 | Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients |
| Q37181531 | Integrated genomic analysis of breast cancers |
| Q34066320 | Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer |
| Q35891590 | Integrative and regularized principal component analysis of multiple sources of data |
| Q34419090 | Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. |
| Q38213543 | Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy |
| Q36910353 | Luminal B breast cancer subtype displays a dicotomic epigenetic pattern |
| Q37410615 | MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. |
| Q42065079 | Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions |
| Q49871101 | Metabolic Footprints and Molecular Subtypes in Breast Cancer |
| Q35627478 | Metabolic Signatures of Human Breast Cancer |
| Q92877117 | Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer |
| Q34991280 | Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer |
| Q42472194 | Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients |
| Q35000210 | Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features |
| Q38503758 | Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer |
| Q34168437 | Methylation-mediated gene silencing as biomarkers of gastric cancer: a review |
| Q38388111 | Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value. |
| Q26775086 | MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer |
| Q48229387 | Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative. |
| Q37608340 | Modeling precision treatment of breast cancer |
| Q34476551 | Molecular characterisation of cell line models for triple-negative breast cancers |
| Q89283561 | Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data |
| Q47662300 | Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia |
| Q49478791 | Nonlinear Joint Latent Variable Models and Integrative Tumor Subtype Discovery |
| Q39179314 | Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis. |
| Q36957198 | Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance |
| Q35008011 | Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors |
| Q41503078 | Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype. |
| Q33989254 | Remodeling of the methylation landscape in breast cancer metastasis. |
| Q35963443 | Role of epigenetic modifications in luminal breast cancer |
| Q26865846 | SLUG: Critical regulator of epithelial cell identity in breast development and cancer |
| Q30768936 | SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS. |
| Q52575440 | Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns. |
| Q64270020 | Stratification of Breast Cancer by Integrating Gene Expression Data and Clinical Variables |
| Q36268784 | Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines |
| Q88013658 | TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours |
| Q38944944 | The CpG island methylator phenotype in breast cancer is associated with the lobular subtype |
| Q57107038 | The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge |
| Q57788515 | The Role of Testin in Human Cancers |
| Q54322290 | The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women. |
| Q36924454 | The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition |
| Q58327099 | The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits |
| Q31031642 | Towards understanding the breast cancer epigenome: a comparison of genome-wide DNA methylation and gene expression data |
| Q91871905 | Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer |
| Q47804937 | Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes |
Search more.